Biotech Acquisition Co - Warrants (30/11/2027) Common Stock

Biotech Acquisition Co - Warrants (30/11/2027) posts a common stock of $230M as of September 2022. That compares with $230M in the prior-year period — up 0.6% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Biotech Acquisition Co - Warrants (30/11/2027)'s common stock was $230M. The latest reading is $230M — a 0.6% year-over-year increase (period ending September 2022). Use the history and growth charts on this page for a longer lookback.

Common Stock is one piece of Biotech Acquisition Co - Warrants (30/11/2027)'s financial statement story. At $230M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for BIOTW's common stock usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Biotech Acquisition Co - Warrants (30/11/2027)'s other metric pages and overview cover the third.